Dr. Jeff Lombardo, PharmD, BCOP, Research Assistant Professor, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo discusses chemotherapy compounding, related safety issues, and the advantages of INFUGEM™ (gemcitabine hydrochloride in 0.9% sodium chloride injection).
Empire State Patient Safety Assurance Network
Center for Integrated Global Biomedical Sciences
Research Assistant Professor
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
Buffalo, New York
Last modified: November 17, 2020